Atjaunināt sīkdatņu piekrišanu

Sanford Guide to Antimicrobial Therapy 42nd 2012 ed. [Mīkstie vāki]

4.40/5 (402 ratings by Goodreads)
Edited by , Edited by , Edited by , Edited by , Edited by
  • Formāts: Paperback / softback, 232 pages, height x width x depth: 160x109x10 mm, weight: 91 g, Tables, black and white
  • Sērija : Sanford Guide to Animicrobial Therapy
  • Izdošanas datums: 01-Apr-2012
  • Izdevniecība: Antimicrobial Therapy
  • ISBN-10: 1930808704
  • ISBN-13: 9781930808706
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 30,62 €*
  • * Šī grāmata vairs netiek publicēta. Jums tiks paziņota lietotas grāmatas cena
  • Šī grāmata vairs netiek publicēta. Jums tiks paziņota lietotas grāmatas cena.
  • Daudzums:
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
Sanford Guide to Antimicrobial Therapy 42nd 2012 ed.Palielināt
  • Formāts: Paperback / softback, 232 pages, height x width x depth: 160x109x10 mm, weight: 91 g, Tables, black and white
  • Sērija : Sanford Guide to Animicrobial Therapy
  • Izdošanas datums: 01-Apr-2012
  • Izdevniecība: Antimicrobial Therapy
  • ISBN-10: 1930808704
  • ISBN-13: 9781930808706
Citas grāmatas par šo tēmu:
Permanent link: https://www.kriso.lv/db/9781930808706.html
Abbreviations 2(2)
Table 1 Clinical Approach to Initial Choice of Antimicrobial Therapy 4(63)
Table 2 Recommended Antimicrobial Agents Against Selected Bacteria 67(3)
Table 3 Suggested Duration of Antibiotic Therapy in Immunocompetent Patients 70(1)
Table 4 Comparison of Antibacterial Spectra 71(6)
Table 5A Treatment Options For Systemic Infection Due To Selected Resistant Grant-Positive Bacteria 77(1)
Table 5B Treatment Options for System Infection Due to Selected Multi-Drug Resistant Gram-Negative Bacilli 77(1)
Table 6 Suggested Management of Suspected or Culture-Positive Community-Associated Methicillin-Resistant S. Aureus Infections 78(2)
Table 7 Methods for Drug Desensitization 80(1)
Table 8 Risk Categories of Antimicrobics In Pregnancy 81(1)
Table 9A Selected Pharmacologic Features of Antimicrobial Agents 82(9)
Table 9B Pharmacodynamics of Antibacterials 91(1)
Table 9C Cytochroma P450 interactions of Antimicrobials 91(1)
Table 10A Selected Antibacterial Agents—Adverse Reactions-Overview 92(4)
Table 10B Antimicrobial Agents Associated With Photosensitivity 96(1)
Table 10C Antibiotic Dosage and Side-Effects 97(10)
Table 10D Aminoglycoside Once-Daily and Multiple Daily Dosing Regimens 107(1)
Table 10E Prolonged or Continuous Infusion Dosing of Selected Beta Lactams 108(1)
Table 11A Treatment of Fungal Infections-Antimicrobial Agents of Choice 109(13)
Table 11B Antifungal Drugs: Dosage, Adverse Effects, Comments 122(3)
Table 11C At A Glance Summary of Suggested Antifungal Drugs Against Treatable Pathogenic Fungi 125(1)
Table 12A Treatment of Mycobacterial Infections 126(10)
Table 12B Dosage and Adverse Effects of Antimycobacterial Drugs 136(3)
Table 13A Treatment of Parasitic Infections 139(11)
Table 13B Dosage and Selected Adverse Effects of Antiparasitic Drugs 150(3)
Table 13C Parasites that Cause Eosinophilla (Eosinophilla In Travelers) 153(1)
Table 13D Sources for Hard-to-Find Antiparasitic Drugs 153(1)
Table 14A Antiviral Therapy (Non-HIV) 154(15)
Table 14B Antiviral Drugs (Non-HIV) 169(5)
Table 14C At A Glance Summary of Suggested Antiviral Agents Against Treatable Pathogenic Viruses 174(1)
Table 14D Antiretroviral Therapy In Treatment-Naive Adults (HIV/AIDS) 175(11)
Table 14E Antiretroviral Drugs and Adverse Effects (HIV/AIDS) 186(4)
Table 15A Antimicrobial Prophylexia for Selected Bacterial 190(1)
Table 15B Surgical Antibiotic Prophylaxis 191(4)
Table 15C Antimicrobial Prophylaxis for the Prevention of Bacterial Endocarditis in Patients with Underlying Cardiac Conditions 195(1)
Table 15D Management of Exposure to HIV-1 and Hepatitis B end C 196(3)
Table 15E Prevention of Selected Opportunistic Infections In Human Hematopoietic Cell Transplantation (HCT) or Solid Organ Transplantation (SOT) in Adults With Normal Renal Function 199(2)
Table 16 Pediatric Dosages of Selected Antibacterial Agents 201(1)
Table 17A Dosages of Antimicrobial Drugs in Adult Patients with Renal Impairment 202(8)
Table 17B No Dosage Adjustment with Renal Insufficiency by Category 210(1)
Table 18 Antimicrobials and Hepatic Disease: Dosage Adjustment 210(1)
Table 19 Treatment of CAPD Peritonitis in Adults 210(1)
Table 20A Anti-Tetanus Prophylaxis, Wound Classification, Immunization 211(1)
Table 20B Rabies Postexposure Prophylaxis 212(1)
Table 21 Selected Directory of Resources 213(1)
Table 22A Anti-Infective Drug-Drug interactions 214(7)
Table 22B Drug-Drug Interactions Between Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIB) and Protease Inhibitors 221(1)
Table 23 List of Generic and Common Trade Names 222(2)
Index Of Major Entities 224